临床研究与产品开发 Master of Clinical Research and Product Development

Since 2023, the HKSAR Government has initiated plans to develop Hong Kong into a Health and Medical Innovation Hub. One of the initiatives is the establishment of the Hong Kong Centre for Medical Products Regulation (CMPR), which is targeted to operate by the end of 2026. Once established, Hong Kong will be able to independently approve new medical products through its own regulatory system, reducing reliance on overseas approvals. This important development is expected to accelerate access to innovative medical treatments and stimulate growth in medical research and development across Hong Kong, the Greater Bay Area (GBA), and neighbouring regions.